BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prozac
,
rs7903146
,
FOXP1
,
Metabolism of xenobiotics
,
Leukemia
,
Intestine
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glucose transporter type 5
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
OMIM - Congenital disorder
Adipose tissue of diabetic, glucose intolerant and obese patients expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Developmental changes and fructose absorption in children: effect on malabsorption testing and dieta…
Transepithelial D-glucose and D-fructose transport across the American lobster, Homarus americanus, …
Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue.
Is [(99m)Tc]glucarate uptake mediated by fructose transporter GLUT-5?
GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
The Glucose Transporter Type I Deficiency (G1D) Registry
Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
Effects of Glucose-fructose Drinks During Training on Lactate Transport
Fructose and Glucose and TAS1R2 in Type 1 Diabetes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ